132 related articles for article (PubMed ID: 14522108)
1. The susceptibility of non-fermentative Gram-negative bacilli to cefperazone and sulbactam compared with other antibacterial agents.
Fu W; Demei Z; Shi W; Fupin H; Yingyuan Z
Int J Antimicrob Agents; 2003 Oct; 22(4):444-8. PubMed ID: 14522108
[TBL] [Abstract][Full Text] [Related]
2. [Changes of antimicrobial resistance among nonfermenting gram-negative bacilli isolated from intensive care units from 1994 to 2001 in China].
Wang H; Chen MJ;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):385-90. PubMed ID: 12820914
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of cefoperazone-sulbactam combination against gram negative bacilli.
Poudyal N; Gyawali N; Gurung R; Bhattarai NR; Baral R; Khanal B; Shrestha S; Amatya R; Bhattacharya SK
Nepal Med Coll J; 2012 Mar; 14(1):5-8. PubMed ID: 23441486
[TBL] [Abstract][Full Text] [Related]
4. ['In vitro' activity of different antimicrobial agents on Gram-negative nonfermentative bacilli, excluding Pseudomonas aeruginosa and Acinetobacter spp].
Vay CA; Almuzara MN; Rodríguez CH; Pugliese ML; Lorenzo Barba F; Mattera JC; Famiglietti AM
Rev Argent Microbiol; 2005; 37(1):34-45. PubMed ID: 15991478
[TBL] [Abstract][Full Text] [Related]
5. [In vitro antimicrobial activity of piperacillin-sulbactam and other 7 antimicrobial agents against non-fermentative bacilli].
Zhuo C; Xiao SN; Qiu GX; Zhong NS
Zhonghua Nei Ke Za Zhi; 2010 Dec; 49(12):1015-9. PubMed ID: 21211358
[TBL] [Abstract][Full Text] [Related]
6. [The reliability of using impenem, meropenem, cefoperazone-sulbactam and piperacillin-tazobactam to treat nosocomial Gram-negative bacterial infections with Monte Carlo simulation].
Xiao YH; Hu YJ
Zhonghua Nei Ke Za Zhi; 2017 Aug; 56(8):595-600. PubMed ID: 28789493
[No Abstract] [Full Text] [Related]
7. [Analysis of the distribution characteristics and drug resistance of non-fermenting bacterial infection in intensive care unit from 2009 to 2015].
Hao D; Hu Z; Liu X; Sun T; Wang T; Tian H; Wang X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 May; 28(5):439-44. PubMed ID: 29920041
[TBL] [Abstract][Full Text] [Related]
8. Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group.
Jones RN; Salazar JC; Pfaller MA; Doern GV
Diagn Microbiol Infect Dis; 1997 Dec; 29(4):265-72. PubMed ID: 9458984
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial activity of tigecycline and cefoperazone/sulbactam tested against 18,386 Gram-negative organisms from Europe and the Asia-Pacific region (2013-2014).
Pfaller MA; Flamm RK; Duncan LR; Mendes RE; Jones RN; Sader HS
Diagn Microbiol Infect Dis; 2017 Jun; 88(2):177-183. PubMed ID: 28341098
[TBL] [Abstract][Full Text] [Related]
10. [In vitro antibacterial activity of cefoperazone-sulbactam].
Zhang Y; Zhang J; Zhou L
Zhonghua Nei Ke Za Zhi; 1995 Oct; 34(10):676-9. PubMed ID: 8731829
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial activity of cefoperazone-sulbactam tested against Gram-Negative organisms from Europe, Asia-Pacific, and Latin America.
Sader HS; Carvalhaes CG; Streit JM; Castanheira M; Flamm RK
Int J Infect Dis; 2020 Feb; 91():32-37. PubMed ID: 31715325
[TBL] [Abstract][Full Text] [Related]
12. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
Chen MJ; Wang H;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912
[TBL] [Abstract][Full Text] [Related]
13. [Distribution and drug-resistance of 3 500 gram-negative bacteria in Guangzhou].
Xiao QZ; Su DH; Jiang JH; Zhong NS
Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):132-8. PubMed ID: 15698988
[TBL] [Abstract][Full Text] [Related]
14. In-vitro susceptibility of cefoperazone-susceptible and -resistant gram-negative rods to cefoperazone plus sulbactam, other beta-lactams, aminoglycosides and quinolone.
Chandrasekar PH; Sluchak JA
Infection; 1991; 19(1):49-53. PubMed ID: 2013510
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of antibacterial activities of various antibiotics against glucose non-fermentative gram-negative rods other than Pseudomonas aeruginosa].
Kouda M; Fukuhara J; Takeuchi M; Ohgawara M; Matsuzaki H; Tohi H; Furuhata N; Maruyama M; Sasaki K; Sawabe E; Ikeda A; Suzuki T; Satoh H; Takahashi I; Kimura F; Nomura H; Ono E
Jpn J Antibiot; 1998 Jul; 51(7):475-87. PubMed ID: 9755431
[TBL] [Abstract][Full Text] [Related]
16. [Antimicrobial resistance monitoring of gram-negative bacilli isolated from 15 teaching hospitals in 2014 in China].
Wang Q; Wang H; Yu Y; Xu X; Sun Z; Lu J; Yang B; Zhang L; Hu Z; Feng X; Xu Y; Ni Y; Mei Y; Liao K; Ji P; Chu Y
Zhonghua Nei Ke Za Zhi; 2015 Oct; 54(10):837-45. PubMed ID: 26675021
[TBL] [Abstract][Full Text] [Related]
17. Comparison of commonly used antimicrobial susceptibility testing methods for evaluating susceptibilities of clinical isolates of Enterobacteriaceae and nonfermentative Gram-negative bacilli to cefoperazone-sulbactam.
Jean SS; Liao CH; Sheng WH; Lee WS; Hsueh PR
J Microbiol Immunol Infect; 2017 Aug; 50(4):454-463. PubMed ID: 26454423
[TBL] [Abstract][Full Text] [Related]
18. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005].
Yang QW; Xu YC; Chen MJ; Hu YJ; Ni YX; Sun JY; Yu YS; Kong HS; He L; Wu WY; Ye HF; Yang YM; Zhu LN; Guo SH; Ji P; Zhu ZH; Ren JK; Zhang LX; Sun ZY; Zhu XH; Tong MQ; Zhao WS; Mei YN; Liu Y; Zhang ZJ; Duan Q; Li D; Liu PP; Wang J; Han LX; Wang H; Xie XL
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2753-8. PubMed ID: 18167265
[TBL] [Abstract][Full Text] [Related]
19. Survey of antibiotic susceptibility among gram-negative bacilli at a cancer center.
Rolston KV; Elting L; Waguespack S; Ho DH; LeBlanc B; Bodey GP
Chemotherapy; 1996; 42(5):348-53. PubMed ID: 8874974
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of cefoperazone-sulbactam: Singapore experience.
Kumarasinghe G; Chow C; Chiu C; Cheong YM
Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):734-7. PubMed ID: 9253876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
